No Data
Tokyo-based retailer sees continued sharp decline; September same-store sales turn negative for the first time in 23 months
The stock continued to decline sharply. Last weekend, the company released its monthly sales figures for September. Comparable-store sales fell 1.5% year over year, marking the first year-over-year
Morning Session [Active Stocks / Notable Movers]
*TDK 3,455 +257It is reported that sales to the AI market are expected to exceed the plan.*Renesas Electronics 3854 +279And expectations of price increases for power management ICs, among other
October 5 [Today's Investment Strategy]
[FISCO Featured Stock][Stock Name] JCR Pharma ¥484 (Oct. 2)The company's core product is a human growth hormone formulation. It announced that it has entered into an exclusive licensing agreement
Focus on IDEC and JCR Pharma; Inflonix HD and Zuiko appear weak.
Last weekend, on the U.S. stock market, the Dow Jones Industrial Average closed up $250.40 at 51,176.96, the Nasdaq Composite rose 319.26 points to 27,190.86, and Chicago‑based Nikkei 225 futures
TOKYO BASE Posts Solid September Sales and Ramps Up Autumn-Winter Inventory
TOKYO BASE Releases 1H FY2027/1 Briefing on Performance and ESG Strategy